The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended the first advanced therapy medicinal product containing stem cells for approval in the European Union. The product treats limbal stem cell deficiency, a rare eye condition that can result in blindness.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
